Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 766

1.

A 24-week Anemia Correction Study of Daprodustat in Japanese Dialysis Patients.

Tsubakihara Y, Akizawa T, Nangaku M, Onoue T, Yonekawa T, Matsushita H, Endo Y, Cobitz A.

Ther Apher Dial. 2019 Jul 15. doi: 10.1111/1744-9987.12962. [Epub ahead of print]

PMID:
31306555
2.

Challenges for real-time intraoperative diagnosis of high risk histology in lung adenocarcinoma: A necessity for sublobar resection.

Takahashi Y, Kuroda H, Oya Y, Matsutani N, Matsushita H, Kawamura M.

Thorac Cancer. 2019 Jul 9. doi: 10.1111/1759-7714.13133. [Epub ahead of print] Review.

PMID:
31287246
3.

Overcoming Tyrosine Kinase Inhibitor Resistance in Transformed Cell Harboring SEPT9-ABL1 Chimeric Fusion Protein.

Kawai H, Matsushita H, Suzuki R, Kitamura Y, Ogawa Y, Kawada H, Ando K.

Neoplasia. 2019 Jul 2;21(8):788-801. doi: 10.1016/j.neo.2019.06.001. [Epub ahead of print]

4.

Bone marrow involvement by monomorphic epitheliotropic intestinal T-cell lymphoma.

Ikeda C, Maruyama D, Oka H, Fujino T, Maeshima AM, Matsushita H.

Br J Haematol. 2019 Jun 25. doi: 10.1111/bjh.16073. [Epub ahead of print] No abstract available.

PMID:
31240703
5.

Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria.

Liang S, Zhong Z, Kim SY, Uchiyama R, Roh YS, Matsushita H, Gottlieb RA, Seki E.

J Biol Chem. 2019 Jun 24. pii: jbc.RA119.007409. doi: 10.1074/jbc.RA119.007409. [Epub ahead of print]

6.

Alcohol and hepatocellular carcinoma.

Matsushita H, Takaki A.

BMJ Open Gastroenterol. 2019 Apr 3;6(1):e000260. doi: 10.1136/bmjgast-2018-000260. eCollection 2019. Review.

7.

Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma.

Nejo T, Matsushita H, Karasaki T, Nomura M, Saito K, Tanaka S, Takayanagi S, Hana T, Takahashi S, Kitagawa Y, Koike T, Kobayashi Y, Nagae G, Yamamoto S, Ueda H, Tatsuno K, Narita Y, Nagane M, Ueki K, Nishikawa R, Aburatani H, Mukasa A, Saito N, Kakimi K.

Cancer Immunol Res. 2019 Jul;7(7):1148-1161. doi: 10.1158/2326-6066.CIR-18-0599. Epub 2019 May 14.

PMID:
31088845
8.

Glutamate Dehydrogenase from Thermus thermophilus Is Activated by AMP and Leucine as a Complex with Catalytically Inactive Adenine Phosphoribosyltransferase Homolog.

Tomita T, Matsushita H, Yoshida A, Kosono S, Yoshida M, Kuzuyama T, Nishiyama M.

J Bacteriol. 2019 Jun 21;201(14). pii: e00710-18. doi: 10.1128/JB.00710-18. Print 2019 Jul 15.

PMID:
31036724
9.

Anti-IL-10 antibody in systemic lupus erythematosus.

Uchida M, Ooka S, Goto Y, Suzuki K, Fujimoto H, Ishimori K, Matsushita H, Takakuwa Y, Kawahata K.

Open Access Rheumatol. 2019 Mar 26;11:61-65. doi: 10.2147/OARRR.S191953. eCollection 2019.

10.

Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer.

Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Gastrointest Oncol. 2019 Jan 15;11(1):17-27. doi: 10.4251/wjgo.v11.i1.17.

11.

Placental hypoplasia and maternal organic vascular disorder in pregnant women with gestational hypertension and preeclampsia.

Owaki Y, Watanabe K, Iwasaki A, Saitou T, Matsushita H, Wakatsuki A.

J Matern Fetal Neonatal Med. 2019 May 2:1-7. doi: 10.1080/14767058.2019.1608175. [Epub ahead of print]

PMID:
30983440
12.

Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset.

Nakanishi K, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Gastric Cancer. 2019 Apr 6. doi: 10.1007/s10120-019-00961-9. [Epub ahead of print]

PMID:
30955110
13.

A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma.

Kawai H, Matsushita H, Kawakami S, Furuya D, Shiraiwa-Hara S, Ichiki A, Hara R, Aoyama Y, Ogiya D, Suzuki R, Machida S, Onizuka M, Shirasugi Y, Ogawa Y, Kawada H, Nakamura N, Ando K.

J Clin Exp Hematop. 2019;59(1):34-39. doi: 10.3960/jslrt.18038.

14.

A Net Mold-Based Method of Biomaterial-Free Three-Dimensional Cardiac Tissue Creation.

Yang B, Lui C, Yeung E, Matsushita H, Jeyaram A, Pitaktong I, Inoue T, Mohamed Z, Ong CS, DiSilvestre D, Jay SM, Tung L, Tomaselli G, Ma C, Hibino N.

Tissue Eng Part C Methods. 2019 Apr;25(4):243-252. doi: 10.1089/ten.TEC.2019.0003.

PMID:
30913987
15.

FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer.

Jingu K, Umezawa R, Yamamoto T, Takeda K, Ishikawa Y, Takahashi N, Kadoya N, Matsushita H.

Int J Clin Oncol. 2019 Aug;24(8):927-933. doi: 10.1007/s10147-019-01428-8. Epub 2019 Mar 12.

PMID:
30863993
16.

The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset.

Sasahara M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Dig Surg. 2019 Mar 6:1-10. doi: 10.1159/000497454. [Epub ahead of print]

PMID:
30840952
17.

Hypofractionated Radiotherapy for Anaplastic Thyroid Carcinoma: 15 Years of Experience in a Single Institution.

Takahashi N, Matsushita H, Umezawa R, Yamamoto T, Ishikawa Y, Katagiri Y, Tasaka S, Takeda K, Fukui K, Kadoya N, Ito K, Jingu K.

Eur Thyroid J. 2019 Jan;8(1):24-30. doi: 10.1159/000493315. Epub 2018 Oct 4.

18.

Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study.

Sunami K, Ichikawa H, Kubo T, Kato M, Fujiwara Y, Shimomura A, Koyama T, Kakishima H, Kitami M, Matsushita H, Furukawa E, Narushima D, Nagai M, Taniguchi H, Motoi N, Sekine S, Maeshima A, Mori T, Watanabe R, Yoshida M, Yoshida A, Yoshida H, Satomi K, Sukeda A, Hashimoto T, Shimizu T, Iwasa S, Yonemori K, Kato K, Morizane C, Ogawa C, Tanabe N, Sugano K, Hiraoka N, Tamura K, Yoshida T, Fujiwara Y, Ochiai A, Yamamoto N, Kohno T.

Cancer Sci. 2019 Apr;110(4):1480-1490. doi: 10.1111/cas.13969. Epub 2019 Apr 2.

19.

Proposal of a Scoring Scale to Estimate Risk of the Discontinuation of S-1 Adjuvant Monotherapy in Patients with Stage II to III Gastric Cancer: A Multi-Institutional Dataset Analysis.

Iizuka A, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Surg. 2019 Aug;43(8):2016-2024. doi: 10.1007/s00268-019-04942-y.

PMID:
30737551
20.

Successful screening of sleep-disordered breathing using a pacemaker-based algorithm in Japan.

Taguchi Y, Matsushita K, Ishikawa T, Matsumoto K, Hosoda J, Iguchi K, Matsushita H, Kubota K, Sumita S, Ishigami T, Tamura K.

J Cardiol. 2019 May;73(5):394-400. doi: 10.1016/j.jjcc.2018.10.007. Epub 2019 Jan 7.

PMID:
30630655
21.

[Field Shape Optimization Technique Based on Dose Volume Histogram Using Daily Cone-beam Computed Tomography in Three-dimensional Conformal Radiation Therapy for Localized Prostate Cancer: Develop and Evaluation].

Kimura Y, Dobashi S, Ishizawa Y, Kadoya N, Ito K, Chiba T, Takayama Y, Sato K, Matsushita H, Jingu K, Takeda K.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018 Dec;74(12):1396-1405. doi: 10.6009/jjrt.2018_JSRT_74.12.1396. Japanese.

22.

The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set.

Ryo S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Ann Surg Oncol. 2019 Feb;26(2):456-464. doi: 10.1245/s10434-018-07121-w. Epub 2018 Dec 18.

PMID:
30565044
23.

Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset.

Hayashi S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Gastric Cancer. 2019 Jul;22(4):853-863. doi: 10.1007/s10120-018-0902-2. Epub 2018 Nov 27.

PMID:
30483985
24.

Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi-institutional dataset.

Nakagawa N, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Cancer Med. 2018 Dec;7(12):6020-6029. doi: 10.1002/cam4.1868. Epub 2018 Nov 8.

25.

Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-institutional Dataset.

Ito Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Surg. 2019 Mar;43(3):870-877. doi: 10.1007/s00268-018-4834-0.

PMID:
30377722
26.

Perfluorocarbon-Based 19 F MRI Nanoprobes for In Vivo Multicolor Imaging.

Akazawa K, Sugihara F, Nakamura T, Matsushita H, Mukai H, Akimoto R, Minoshima M, Mizukami S, Kikuchi K.

Angew Chem Int Ed Engl. 2018 Dec 17;57(51):16742-16747. doi: 10.1002/anie.201810363. Epub 2018 Nov 27.

27.

Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review.

Matsushita H, Jingu K, Umezawa R, Yamamoto T, Ishikawa Y, Takahashi N, Katagiri Y, Kadoya N.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818803597. doi: 10.1177/1533033818803597. Review.

28.

Controversial issues in radiotherapy after breast-conserving surgery for early breast cancer in older patients: a systematic review.

Tang L, Matsushita H, Jingu K.

J Radiat Res. 2018 Nov 1;59(6):789-793. doi: 10.1093/jrr/rry071.

29.

Royal jelly does not prevent bone loss but improves bone strength in ovariectomized rats.

Shimizu S, Matsushita H, Minami A, Kanazawa H, Suzuki T, Watanabe K, Wakatsuki A.

Climacteric. 2018 Dec;21(6):601-606. doi: 10.1080/13697137.2018.1517739. Epub 2018 Oct 9.

PMID:
30296854
30.

Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer.

Yamamoto T, Kadoya N, Morishita Y, Sato Y, Matsushita H, Umezawa R, Ishikawa Y, Takahashi N, Katagiri Y, Takeda K, Jingu K.

PLoS One. 2018 Oct 4;13(10):e0204734. doi: 10.1371/journal.pone.0204734. eCollection 2018.

31.

Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes.

Tsuchiya K, Tabe Y, Ai T, Ohkawa T, Usui K, Yuri M, Misawa S, Morishita S, Takaku T, Kakimoto A, Yang H, Matsushita H, Hanami T, Yamanaka Y, Okuzawa A, Horii T, Hayashizaki Y, Ohsaka A.

PLoS One. 2018 Oct 3;13(10):e0202429. doi: 10.1371/journal.pone.0202429. eCollection 2018.

32.

Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702).

Onimaru R, Onishi H, Ogawa G, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Shirato H.

Jpn J Clin Oncol. 2018 Dec 1;48(12):1076-1082. doi: 10.1093/jjco/hyy141.

33.

A case of lung tumorlets secondary to pulmonary hypoplasia with recurrent haemoptysis.

Yagyu K, Miyamoto A, Matsushita H, Okimora A.

Respirol Case Rep. 2018 Sep 28;6(8):e00373. doi: 10.1002/rcr2.373. eCollection 2018 Nov.

34.

<Editors' Choice> Efficacy of enteral nutrients containing β-hydroxy-β-methylbutyrate, glutamine, and arginine for the patients with anastomotic leakage after gastrectomy: study protocol of a multicenter phase II clinical trial.

Kanda M, Tanaka C, Murotani K, Kobayashi D, Ito S, Mochizuki Y, Ishigure K, Ishiyama A, Teramoto H, Murai T, Asada T, Matsushita H, Fujiwara M, Kodera Y.

Nagoya J Med Sci. 2018 Aug;80(3):351-355. doi: 10.18999/nagjms.80.3.351.

35.

A simple screening method for the diagnosis of chronic myeloid leukemia using the parameters of a complete blood count and differentials.

Ogasawara A, Matsushita H, Tanaka Y, Shirasugi Y, Ando K, Asai S, Miyachi H.

Clin Chim Acta. 2019 Feb;489:249-253. doi: 10.1016/j.cca.2018.08.038. Epub 2018 Aug 27.

PMID:
30165034
36.

Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis.

Jingu K, Matsushita H, Yamamoto T, Umezawa R, Ishikawa Y, Takahashi N, Katagiri Y, Takeda K, Kadoya N.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818794936. doi: 10.1177/1533033818794936.

37.

A Net Mold-based Method of Scaffold-free Three-Dimensional Cardiac Tissue Creation.

Bai Y, Yeung E, Lui C, Ong CS, Pitaktong I, Huang C, Inoue T, Matsushita H, Ma C, Hibino N.

J Vis Exp. 2018 Aug 5;(138). doi: 10.3791/58252.

PMID:
30124650
38.

Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.

Hashimoto J, Kato K, Ito Y, Kojima T, Akimoto T, Daiko H, Hamamoto Y, Matsushita H, Katano S, Hara H, Tanaka Y, Saito Y, Nagashima K, Igaki H.

Int J Clin Oncol. 2019 Jan;24(1):60-67. doi: 10.1007/s10147-018-1336-x. Epub 2018 Aug 14.

PMID:
30109544
39.

Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study.

Onishi H, Yamashita H, Shioyama Y, Matsumoto Y, Takayama K, Matsuo Y, Miyakawa A, Matsushita H, Aoki M, Nihei K, Kimura T, Ishiyama H, Murakami N, Nakata K, Takeda A, Uno T, Nomiya T, Takanaka T, Seo Y, Komiyama T, Marino K, Aoki S, Saito R, Araya M, Maehata Y, Tominaga L, Kuriyama K.

Cancers (Basel). 2018 Aug 2;10(8). pii: E257. doi: 10.3390/cancers10080257.

40.

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database.

Shioyama Y, Onishi H, Takayama K, Matsuo Y, Takeda A, Yamashita H, Miyakawa A, Murakami N, Aoki M, Matsushita H, Matsumoto Y, Shibamoto Y; Japanese Radiological Society Multi-Institutional SBRT Study Group (JRS-SBRTSG).

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818783904. doi: 10.1177/1533033818783904.

41.

Impact of change in serum albumin level during and after chemoradiotherapy in patients with locally advanced esophageal cancer.

Takeda K, Umezawa R, Takahashi N, Matsushita H, Kozumi M, Ishikawa Y, Yamamoto T, Takeda K, Jingu K.

Esophagus. 2018 Jul;15(3):190-197. doi: 10.1007/s10388-018-0612-1. Epub 2018 Mar 26.

PMID:
29951984
42.

Correction to: Dysplastic features seen in a patient with acute myeloid leukemia harboring the KMT2A-TET1 fusion gene.

Kawai H, Matsushita H, Aoyama Y, Matsui K, Onizuka M, Ando K.

Int J Hematol. 2018 Aug;108(2):232. doi: 10.1007/s12185-018-2476-5.

PMID:
29948955
43.

Surface microstructures are associated with mutational intratumoral heterogeneity in colorectal tumors.

Harada T, Yamamoto E, Yamano HO, Aoki H, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Tanaka Y, Yoshida Y, Eizuka M, Yorozu A, Sudo G, Kitajima H, Niinuma T, Kai M, Sasaki Y, Tokino T, Sugai T, Nakase H, Suzuki H.

J Gastroenterol. 2018 Dec;53(12):1241-1252. doi: 10.1007/s00535-018-1481-z. Epub 2018 Jun 11.

PMID:
29948303
44.

Dysplastic features seen in a patient with acute myeloid leukemia harboring the KTM2A-TET1 fusion gene.

Kawai H, Matsushita H, Aoyama Y, Matsui K, Onizuka M, Ando K.

Int J Hematol. 2018 Jul;108(1):1-2. doi: 10.1007/s12185-018-2469-4. Epub 2018 May 9. No abstract available. Erratum in: Int J Hematol. 2018 Aug;108(2):232.

PMID:
29744807
45.

Log file-based patient dose calculations of double-arc VMAT for head-and-neck radiotherapy.

Katsuta Y, Kadoya N, Fujita Y, Shimizu E, Majima K, Matsushita H, Takeda K, Jingu K.

Phys Med. 2018 Apr;48:6-10. doi: 10.1016/j.ejmp.2018.03.006. Epub 2018 Mar 20.

PMID:
29728230
46.

Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy.

Kozumi M, Ota H, Yamamoto T, Umezawa R, Matsushita H, Ishikawa Y, Takahashi N, Matsuura T, Takase K, Jingu K.

Eur Radiol. 2018 Oct;28(10):4296-4305. doi: 10.1007/s00330-018-5439-6. Epub 2018 May 3.

47.

Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma.

Imai Y, Hasegawa K, Matsushita H, Fujieda N, Sato S, Miyagi E, Kakimi K, Fujiwara K.

Oncol Lett. 2018 May;15(5):6457-6468. doi: 10.3892/ol.2018.8101. Epub 2018 Feb 21.

48.

Oxytocin Inhibits Corticosterone-induced Apoptosis in Primary Hippocampal Neurons.

Latt HM, Matsushita H, Morino M, Koga Y, Michiue H, Nishiki T, Tomizawa K, Matsui H.

Neuroscience. 2018 May 21;379:383-389. doi: 10.1016/j.neuroscience.2018.03.025. Epub 2018 Mar 27.

PMID:
29596965
49.

Liquid biopsy of bile for the molecular diagnosis of gallbladder cancer.

Kinugasa H, Nouso K, Ako S, Dohi C, Matsushita H, Matsumoto K, Kato H, Okada H.

Cancer Biol Ther. 2018;19(10):934-938. doi: 10.1080/15384047.2018.1456604. Epub 2018 May 4.

50.

Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.

Aoki H, Yamamoto E, Yamano HO, Sugai T, Kimura T, Tanaka Y, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Nakaoka M, Yoshida Y, Harada T, Sudo G, Eizuka M, Yorozu A, Kitajima H, Niinuma T, Kai M, Nojima M, Suzuki H, Nakase H.

Dig Dis Sci. 2018 Jul;63(7):1920-1928. doi: 10.1007/s10620-018-5016-5. Epub 2018 Mar 15.

PMID:
29546645

Supplemental Content

Loading ...
Support Center